<DOC>
	<DOCNO>NCT00726557</DOCNO>
	<brief_summary>Previous intravenous drug abuser chronic hepatitis C substitution therapy ( buprenorphine , methadone ) treat PegIntron Rebetol accord approve European labeling . The study assess tolerability , safety efficacy treatment PegIntron plus Rebetol study population . The objective study collect data prevalence hepatitis C infection drug-substituted patient . The study also compare feasibility HCV ( Hepatitis C Virus ) treatment patient receive Subutex® vs drug substitution pharmacotherapies .</brief_summary>
	<brief_title>Post-marketing Surveillance Study Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol ( P04408/MK-4031-261 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Substance Abuse , Intravenous</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Treatmentnaïve participant relapsers interferon monotherapy Participants chronic hepatitis C infection At least 18 year age Must meet follow laboratory criterion : Platelets &gt; =100,000/mm^3 Neutrophil count &gt; =1,500/mm^3 TSH ( thyroid stimulate hormone ) within normal limit Hemoglobin &gt; =12 g/dL ( female ) ; &gt; =13 g/dL ( male ) Exintravenous drug abuser stable substitution therapy Women childbearing potential must practice adequate contraception routine pregnancy test perform monthly treatment 7 month posttreatment . Sexuallyactive participant must practice acceptable method contraception treatment 7 month posttreatment Any contraindication specify SPC ( Summary Product Characteristics ) approve European labeling Hypersensitivity active substance interferon excipients Pregnant woman Women breastfeed Existence history severe psychiatric condition , particular severe depression , suicidal ideation suicide attempt A history severe preexist cardiac disease , include unstable uncontrolled cardiac disease previous 6 month Severe debilitate medical condition , include participant chronic renal failure creatinine clearance &lt; 50 mL/min Coinfection HIV ( Human Immunodeficiency Virus ) Autoimmune hepatitis history autoimmune disease Severe hepatic dysfunction decompensated cirrhosis liver Preexisting thyroid disease unless control conventional therapy Epilepsy and/or compromise central nervous system function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>